Use of ovarian suppression with endocrine therapy among premenopausal women with breast cancer in the United States, 2001-2016

被引：0
|
作者：
Mayer, Sophie E. [1 ]
Lund, Jennifer L. [1 ]
Pate, Virginia [1 ]
Reeder-Hayes, Katherine E. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1130
引用
收藏
页码：545 / 546
页数：2
相关论文
共 50 条
  • [41] Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer
    Matteo Lambertini
    Lucia Del Mastro
    Giulia Viglietti
    Noam F. Pondé
    Cinzia Solinas
    Evandro de Azambuja
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [42] Ovarian Function Suppression Plus Fulvestrant in Premenopausal Women with Metastatic Breast Cancer
    Bartsch, R.
    Bago-Horvath, Z.
    Pluschnig, U.
    Berghoff, A.
    Dubsky, P.
    Mader, R. M.
    Fitzal, F.
    Gnant, M.
    Zielinski, C. C.
    Steger, G. G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S54 - S54
  • [43] Asthma prevalence among women aged 18 to 44 in the United States: National health and nutrition examination survey 2001-2016
    Flores, Katrina F.
    Bandoli, Gretchen
    Chambers, Christina D.
    Schatz, Michael
    Palmsten, Kristin
    [J]. JOURNAL OF ASTHMA, 2020, 57 (07) : 693 - 702
  • [44] Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States
    Faiz, Ambarina S.
    Guo, Shuang
    Kaveney, Amanda
    Philipp, Claire S.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2021, 32 (06) : 373 - 381
  • [45] Antidepressant dispensing among women with breast cancer, United States, 2001-2018
    Park, Jihye
    Dejene, Sara
    Mayer, Sophie E.
    Kinlaw, Alan
    Nichols, Hazel B.
    Jonsson-Funk, Michele
    Pate, Virginia
    Park, Eliza M.
    Reeder-Hayes, Katherine E.
    Lund, Jennifer L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 31 - 32
  • [46] Concurrent administration of ovarian function suppression and adjuvant endocrine treatment for premenopausal early breast cancer
    Ding, Jinhua
    Jiang, Li
    Wu, Weizhu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2036 - 2044
  • [47] Ovarian ablation by radiotherapy; is it still an option for the ovarian function suppression in endocrine responsive premenopausal breast cancer patients?
    Bese, N. S.
    Iribas, A.
    Oksuz, D. C.
    Atkovar, G.
    Ober, A.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 341S - 341S
  • [48] Controversies in the management of patients with breast cancer: Adjuvant endocrine therapy in premenopausal women
    Parton, Marina
    Smith, Ian E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) : 745 - 752
  • [49] Social Characteristics and Adherence to Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer
    Schmidt, Julie A.
    Woolpert, Kirsten M.
    Hjorth, Cathrine F.
    Farkas, Dora K.
    Ejlertsen, Bent
    Cronin-Fenton, Deirdre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (28)
  • [50] Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer
    Mathew, Aju
    Davidson, Nancy E.
    [J]. BREAST, 2015, 24 : S120 - S125
12345